SEC Form 4 · accession 0001288952-26-000008
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Schmertzler
Director
Period of report
Sep 9, 2026
Accepted (ET)
Sep 11, 2026 · 5:20 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Sep 9, 2026 | S | 9,428 | $67.79 | D | 1,327,166 | I | See footnote |
| Common StockF4,F3 | Sep 9, 2026 | S | 572 | $68.67 | D | 1,326,594 | I | See footnote |
| Common StockF5,F3 | Sep 10, 2026 | S | 10,000 | $67.34 | D | 1,316,594 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $67.54 to $68.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3Represents shares of common stock held by Section Six Partners, L.P. The Reporting Person is a general and limited partner of Section Six Partners, L.P. The Reporting Person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein.
- F4This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.54 to $68.76 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.84 to $67.66 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.